Both of these evidences suggest that GOLM1 was important for ovarian cancer development through regulating B7-H3 protein distribution, which provide further insight towards the B7-H3 targeting therapy and mechanism for ovarian cancer. This evidence concerns the gene GOLM1 and ovarian carcinoma.